Oscar Health (OSCR) to Release Earnings on Wednesday

Oscar Health (NYSE:OSCR - Get Free Report) is expected to issue its quarterly earnings data before the market opens on Wednesday, February 5th. Analysts expect the company to announce earnings of ($0.55) per share and revenue of $2.47 billion for the quarter. Oscar Health has set its FY 2024 guidance at EPS.Persons interested in registering for the company's earnings conference call can do so using this link.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.20) by ($0.02). The company had revenue of $2.42 billion during the quarter, compared to analysts' expectations of $2.33 billion. Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. Oscar Health's quarterly revenue was up 68.3% on a year-over-year basis. During the same period in the previous year, the company earned ($0.29) EPS. On average, analysts expect Oscar Health to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Oscar Health Stock Up 1.5 %

Shares of NYSE:OSCR traded up $0.24 during mid-day trading on Wednesday, hitting $16.52. 855,907 shares of the company traded hands, compared to its average volume of 2,963,599. The firm has a market cap of $4.08 billion, a P/E ratio of -276.87, a PEG ratio of 0.65 and a beta of 1.70. Oscar Health has a 52-week low of $12.48 and a 52-week high of $23.79. The firm's 50 day simple moving average is $15.20 and its 200 day simple moving average is $16.82. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.73 and a current ratio of 0.73.

Insider Transactions at Oscar Health

In other news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction that occurred on Wednesday, November 20th. The stock was sold at an average price of $17.05, for a total transaction of $426,250.00. Following the completion of the transaction, the director now directly owns 89,512 shares in the company, valued at approximately $1,526,179.60. The trade was a 21.83 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Thrive Partners Vii Growth Gp, purchased 420,819 shares of Oscar Health stock in a transaction on Tuesday, November 12th. The shares were acquired at an average price of $13.68 per share, with a total value of $5,756,803.92. Following the transaction, the director now directly owns 5,452,081 shares in the company, valued at $74,584,468.08. This trade represents a 8.36 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have purchased 1,055,478 shares of company stock worth $14,432,852 and have sold 103,610 shares worth $1,847,519. Insiders own 25.11% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on the company. Jefferies Financial Group initiated coverage on Oscar Health in a report on Tuesday, December 10th. They issued an "underperform" rating and a $12.00 price target for the company. UBS Group began coverage on shares of Oscar Health in a report on Monday, October 7th. They issued a "neutral" rating and a $23.00 price target on the stock. Finally, Bank of America downgraded shares of Oscar Health from a "neutral" rating to an "underperform" rating and dropped their target price for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat, Oscar Health currently has a consensus rating of "Hold" and a consensus price target of $21.56.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.